CNR Institutional Research Information System

BONINI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.430
NA - Nord America 1.064
EU - Europa 309
SA - Sud America 244
Continente sconosciuto - Info sul continente non disponibili 23
AF - Africa 10
OC - Oceania 1
Totale 3.081
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.003
SG - Singapore 584
CN - Cina 317
BR - Brasile 193
HK - Hong Kong 157
VN - Vietnam 155
FR - Francia 100
IT - Italia 82
KR - Corea 62
BD - Bangladesh 43
GB - Regno Unito 34
DE - Germania 29
CA - Canada 24
IN - India 23
JP - Giappone 21
NL - Olanda 16
MX - Messico 14
AR - Argentina 12
ID - Indonesia 12
CO - Colombia 11
FI - Finlandia 11
EC - Ecuador 10
IQ - Iraq 9
SA - Arabia Saudita 9
IL - Israele 8
VE - Venezuela 8
RU - Federazione Russa 7
CR - Costa Rica 6
PH - Filippine 6
JM - Giamaica 5
PK - Pakistan 5
TH - Thailandia 5
AT - Austria 4
CL - Cile 4
ES - Italia 4
HN - Honduras 4
IE - Irlanda 3
MA - Marocco 3
MY - Malesia 3
PY - Paraguay 3
SE - Svezia 3
UA - Ucraina 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BS - Bahamas 2
EG - Egitto 2
GR - Grecia 2
JO - Giordania 2
KE - Kenya 2
PL - Polonia 2
TN - Tunisia 2
TR - Turchia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LT - Lituania 1
MQ - Martinica 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 3.059
Salva come PNG Salva come JPEG
Città #
Santa Clara 369
Singapore 336
Hong Kong 156
Hefei 153
San Jose 96
Ashburn 74
Seoul 62
Lauterbourg 55
Ho Chi Minh City 54
Beijing 50
Hanoi 39
New York 39
Los Angeles 20
São Paulo 20
Frankfurt am Main 15
Rome 12
Tokyo 12
Dallas 11
Milan 9
Minamishinagawa 9
Montreal 8
Naples 8
Rio de Janeiro 8
Bengaluru 7
Buffalo 7
Da Nang 7
Haiphong 7
Helsinki 7
Atlanta 6
Biên Hòa 6
Brasília 6
Brooklyn 6
Guangzhou 6
Guayaquil 6
Phoenix 6
Porto Alegre 6
Bexley 5
Boardman 5
Council Bluffs 5
Düsseldorf 5
Las Vegas 5
Nashville 5
Orangeburg 5
Orem 5
Philadelphia 5
San José 5
Agawam 4
Alexandria 4
Baghdad 4
Belo Horizonte 4
Can Tho 4
Cleveland 4
Curitiba 4
Denver 4
Dhaka 4
Houston 4
Jeddah 4
Kingston 4
Lahore 4
Newark 4
Portsmouth 4
Salvador 4
São Gonçalo 4
The Bronx 4
Trento 4
Vienna 4
Albuquerque 3
Bogotá 3
Buenos Aires 3
Calgary 3
Campinas 3
Caracas 3
Chandler 3
Cherry Hill 3
City of London 3
Dublin 3
Elk Grove Village 3
Ha Long 3
Imola 3
Jacksonville 3
Kuala Lumpur 3
Lappeenranta 3
London 3
Minneapolis 3
Modena 3
Mumbai 3
Nuremberg 3
Omaha 3
Queens 3
Roubaix 3
Santiago 3
Toronto 3
Anápolis 2
Arcadia 2
Athens 2
Baku 2
Baltimore 2
Bangkok 2
Belém 2
Betim 2
Totale 1.922
Salva come PNG Salva come JPEG
Nome #
Annotated guidance to the European Medicines Agency (EMA) guidelines and regulatory documents. A new series of the BJCP 157
Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products 86
International consensus on allergy immunotherapy 82
Nerve growth factor (NGF) and lenses: effects of NGF in an in vitro rat model of cataract 81
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals--EAACI recommendations 75
Androgen receptor expression during C2C12 skeletal muscle cell line differentiation 72
Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy). 71
AQUA: Allergy Questionnaire for Athletes. Development and validation 64
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 64
Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma 61
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. 59
Molecular diagnosis and the Italian board for ISAC 57
Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. 57
Is epithelial barrier hypothesis the key to understanding the higher incidence and excess mortality during COVID-19 pandemic? The case of Northern Italy 54
Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. 53
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan--An EAACI position paper 53
Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. 52
Asthma, allergy and the Olympics: a 12-year survey in elite athletes 52
Conjunctival expression of thymosin-â4 in vernal keratoconjunctivitis. 51
Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. 51
Prioritizing research challenges and funding for allergy and asthma and the need for translational research--The European Strategic Forum on Allergic Diseases 51
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence 49
Severe Chronic Allergic (and related) Diseases: a uniform approach- a MeDALL- GA(2)LEN-ARIA Position Paper 49
Barriers to new drug development in respiratory disease 49
Perspectives in allergen immunotherapy: 2019 and beyond 48
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project. 46
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group 46
International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics 45
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update 44
Inhibitor of Fatty Acid Amide Hydrolase - Learning from Tragic Failures REPLY 44
The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases 44
Perspectives in allergen immunotherapy: 2017 and beyond 43
Nerve growth factor effect on human primary fibroblastic-keratocytes: Possible mechanism during corneal healing. 43
Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA 43
A novel adaptive design for allergen immunotherapy clinical trials 42
Biosimilars and drug development in allergic and immunologic diseases 42
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. 39
Nonspecific provocation of target organs in allergic diseases: EAACI-GA(2)LEN consensus report. 38
Epidemiological study on allergy and asthma phenotypes: subclinical and severe asthma. 38
Medical devices in allergy practice 38
Feasibility and challenges of independent research on drugs: the Italian medicines agency (AIFA) experience 38
Nerve Growth Factor Regulates The Production of Lung Mucins in a Transgenic Mice Model of Asthma. 37
Low Levels of Cytokines and Growth Factors in Serum of Allergic and Non-Allergic Top Atletes 37
TLR4 and TLRp expression in different phenotypes of rhinitis 36
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: An EAACI Position Paper 35
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper 34
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: a position paper of the European Academy of Allergy and Clinical Immunology (EAACI) 34
Nerve growth factor modulates in vitro the expression and release of TGF-beta1 by amniotic membrane. 34
Bridging allergologic and botanical knowledge in seasonal allergy: a role for phenology 33
The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta. 33
COVID-19 Clinical trials: Quality matters more than quantity 33
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review 32
A survey of clinical features of allergic rhinitis in adults 31
Allergy and Clinical Immunology Services in Europe 31
Allergic bronchial airway inflammation in nerve growth factor (NGF)-deprived rats: evidence suggesting a neuroimmunomodulatory role of NGF. Exp 30
Clinical relevance is associated with allergen-specific wheal size in skin prick testing 30
Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans? 30
The added value of allergen microarray technique to the management of poly-sensitized allergic patients. 30
Allergy and the eye. 29
Neuropeptide y induces potent migration of human immature dendritic cells and promotes a Th2 polarization 28
Sublingual immunotherapy: World Allergy Organization position paper 2013 update 28
EIB or not EIB? That is the question. 28
Nerve growth factor and tissue repair remodeling: trkANGFR and p75NTR, two receptors one fate 26
The elite athlete: yes, with allergy we can. 25
Innovative medicines: New regulatory procedures for the third millennium 24
An allergist is the new Executive Director of the European Medicine Agency 23
Transparency and the Eropean Medicines Agency- Sharing of Clinical Trial Data 21
Lifestyle, sports activities and allergic diseases 18
Totale 3.081
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.686
article - articoli 10.468
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.154
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 0 0 6 11 10 8
2024/20251.046 7 2 71 35 294 76 1 41 13 41 241 224
2025/20261.646 81 158 138 235 339 42 235 80 89 109 63 77
2026/2027354 97 88 169 0 0 0 0 0 0 0 0 0
Totale 3.081